CELG

Celgene Valued at a Premium - 10/09 - 07:10 AM ET

Celgene Corp. Is Falling After The Close - 10/08 - 05:16 PM ET

COWEN RAISES CELGENE CORP TO OUTPERFORM FROM NEUTRAL - 10/08 - 08:46 AM ET

CELG: To Present At JMP Securities Healthcare Conference @ 10:30 ET [delayed] - 10/07 - 08:53 AM ET

Celgene wins marketing approval for oral myeloma drug in Canada - 10/06 - 11:51 AM ET

Oral Cancer Drug REVLIMID(R) Receives Marketing Authorization from Health Canada for Treatment of Multiple Myeloma - 10/06 - 07:30 AM ET

Celgene (CELG) NewsBite - CELG Rises on Unemployment Relief - 10/03 - 10:15 AM ET

CELG: To Present At Biomarker Discovery Europe Conference @ 04:30 ET [delayed] - 10/03 - 07:53 AM ET

Celgene Corporation to Present at the Third Annual JMP Securities Healthcare Focus Conference - 10/03 - 07:00 AM ET

CELG touches 200-day moving average at 62.99 - 10/03 - 11:11 AM ET

CELG touches 200-day moving average at 62.90 - 09/30 - 10:42 AM ET

The International Myeloma Foundation Says Life-Changing Benefits of REVLIMID(R) Recognized by the Prestigious Prix Galien USA Award 2008 - 09/25 - 08:15 AM ET

CELG: To Present At UBS Global Life Sciences Conference @ 08:00 ET [delayed] - 09/23 - 07:23 AM ET

MethylGene exercises royalty right in cancer drug collaboration with Celgene - 09/22 - 09:33 AM ET

METHYLGENE EXERCISES RIGHT TO CONVERT MGCD0103 COLLABORATION WITH CELGENE TO PRE - 09/19 - 07:33 AM ET

CELG: To Present At Bank of America Investment Conference @ 19:00 ET [delayed] - 09/16 - 05:23 PM ET

CELG: To Present At Merrill Lynch Pharmaceutical Conference @ 11:10 ET [delayed] - 09/16 - 09:54 AM ET

Celgene Corporation to Present at the Bank of America 38th Annual Investment Conference - 09/12 - 04:45 PM ET

Celgene Corporation to Present at Merrill Lynch Global Pharmaceutical Biotech and Medical Devices Conference - 09/12 - 07:30 AM ET

Celgene Hits 2-Month Low On Strong Volume - 09/05 - 12:25 PM ET

Page 1 of 15     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index